Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Dec;19(12):102683.
doi: 10.1016/j.autrev.2020.102683. Epub 2020 Oct 27.

COVID-19 and immune-mediated inflammatory diseases: Why don't our patients get worse?

Víctor M Martínez-Taboada  1 , Marcos López-Hoyos  2 , Javier Crespo  3 , José L Hernández  4
Affiliations

COVID-19 and immune-mediated inflammatory diseases: Why don't our patients get worse?

Víctor M Martínez-Taboada et al. Autoimmun Rev. 2020 Dec.
No abstract available

PubMed Disclaimer

Conflict of interest statement

None.

References

    1. Sarzi-Puttini P., Marotto D., Antivalle M. How to handle patients with autoimmune rheumatic and inflammatory bowel diseases in the COVID-19 era: an expert opinion. Autoimmun Rev. 2020;19(7):102574. - PMC - PubMed
    1. Ehrenfeld M., Tincani A., Andreoli L. Covid-19 and autoimmunity. Autoimmun Rev. 2020;19(8):102597. - PMC - PubMed
    1. Del Papa N., Sambataro G., Minniti A., Pignataro F., Caporali R. Novel COronaVirus disease 2019 (COVID-19) epidemic: what are the risks for systemic sclerosis patients? Autoimmun Rev. 2020;19(7):102558. - PMC - PubMed
    1. Khan N., Patel D., Xie D., Lewis J., Trivedi C., Yang Y.X. Impact of Anti-TNF and Thiopurines medications on the development of COVID-19 in patients with inflammatory bowel disease: a Nationwide VA cohort study. Gastroenterology. 2020;159(4):1545–1546. [published online ahead of print, 2020 May 29] (S0016-5085(20)34737-5) - PMC - PubMed
    1. Brenner E.J., Ungaro R.C., Gearry R.B. Corticosteroids, but not TNF antagonists, are associated with adverse COVID-19 outcomes in patients with inflammatory bowel diseases: results from an international registry. Gastroenterology. 2020 doi: 10.1053/j.gastro.2020.05.032. [published online ahead of print, 2020 May 18] - DOI - PMC - PubMed